Page last updated: 2024-08-21

isoxazoles and Vestibular Diseases

isoxazoles has been researched along with Vestibular Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balabhadrapatruni, S; Darlington, CL; Masumura, C; Smith, PF; Zheng, Y	1
Choi, HK; Poe, DS; Rahman, MU	1

Other Studies

2 other study(ies) available for isoxazoles and Vestibular Diseases

Article	Year
Effects of the putative cognitive-enhancing ampakine, CX717, on attention and object recognition memory. Current Alzheimer research, 2011, Volume: 8, Issue:8 Topics: Animals; Attention; Cognition; Cognition Disorders; Disease Models, Animal; Isoxazoles; Male; Memory; Memory Disorders; Neural Inhibition; Nootropic Agents; Rats; Rats, Wistar; Reaction Time; Recognition, Psychology; Time Factors; Treatment Outcome; Vestibular Diseases	2011
Etanercept therapy for immune-mediated cochleovestibular disorders: preliminary results in a pilot study. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2001, Volume: 22, Issue:5 Topics: Adult; Aged; Antirheumatic Agents; Cochlear Diseases; Etanercept; Female; Follow-Up Studies; Hearing Loss, Sensorineural; Humans; Immunoglobulin G; Isoxazoles; Leflunomide; Male; Middle Aged; Pilot Projects; Receptors, Tumor Necrosis Factor; Retrospective Studies; Tinnitus; Vertigo; Vestibular Diseases	2001

Article

Year

Effects of the putative cognitive-enhancing ampakine, CX717, on attention and object recognition memory.

Current Alzheimer research, 2011, Volume: 8, Issue:8

Topics: Animals; Attention; Cognition; Cognition Disorders; Disease Models, Animal; Isoxazoles; Male; Memory; Memory Disorders; Neural Inhibition; Nootropic Agents; Rats; Rats, Wistar; Reaction Time; Recognition, Psychology; Time Factors; Treatment Outcome; Vestibular Diseases

2011

Etanercept therapy for immune-mediated cochleovestibular disorders: preliminary results in a pilot study.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2001, Volume: 22, Issue:5

Topics: Adult; Aged; Antirheumatic Agents; Cochlear Diseases; Etanercept; Female; Follow-Up Studies; Hearing Loss, Sensorineural; Humans; Immunoglobulin G; Isoxazoles; Leflunomide; Male; Middle Aged; Pilot Projects; Receptors, Tumor Necrosis Factor; Retrospective Studies; Tinnitus; Vertigo; Vestibular Diseases

2001